If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWynnstay Regulatory News (WYN)

Share Price Information for Wynnstay (WYN)

Share Price is delayed by 15 minutes
Get Live Data
375.00    5.00 (1.37%)
Bid:
370.00
Ask:
380.00
Spread: 10.00 (2.703%)
Market Cap: £85.17m
WYN Live PriceLast checked at - London Stock Exchange

Intraday Wynnstay Share Chart

ESOP Trust Transaction

15 Apr 2021 16:19

RNS Number : 6435V
Wynnstay Group PLC
15 April 2021
 

15 April 2021

AIM: WYN

 

WYNNSTAY GROUP PLC

("Wynnstay" or "the Company") 

Wynnstay ESOP Trust Transactions

The Company announces that on 15 April 2021, the Wynnstay ESOP Trust (the "ESOP") sold 24,000 ordinary shares of 25 pence each in the Company ("Ordinary Shares) at a price of 491 pence per Ordinary Share. Following this transaction, the ESOP holding of Ordinary Shares is 16,834 representing approximately 0.08 per cent of the Company's current issued share capital.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details of above transactions.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Wynnstay ESOP Trust (the "ESOP")

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Gareth Davies and Paul Roberts, both directors of the Company, are trustees of the ESOP

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Wynnstay Group plc

 

b)

 

LEI

 

 

213800TOLA726AITR960

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares in the Company

 

 

GB0034212331

 

b)

 

Nature of the transaction

 

 

Sale of shares

c)

 

Price(s) and volume(s)

 

 

Purchase of shares :

 

Price

 

Volume(s)

 

491 pence per share

 

24,000 shares

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Total Value

 

 

 

24,000 Shares

 

491 pence per share

 

£117,840.00

e)

 

Date of the transactions

 

 

15/04/2021

f)

 

Place of the transaction

 

 

LSE, AIM Market (AIMX)

 

 

Enquiries:

 

Wynnstay Group plc

Gareth Davies, Chief Executive

Paul Roberts, Finance Director

 

T: 01691 827142

 

 

 

KTZ Communications

Katie Tzouliadis / Dan Mahoney

T: 020 3178 6378

 

 

 

Shore Capital (Nomad)

Stephane Auton / John More

T: 020 7408 4090

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHIAMATMTBBBRB
Date   Source Headline
15th Feb 20185:09 pmRNSHolding(s) in Company
15th Feb 201810:33 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSFinal Results
31st Oct 201712:00 pmRNSScrip dividend election and PDMR dealing
16th Oct 20173:06 pmRNSAIM Disclosure Update
10th Oct 20175:26 pmRNSAppointment of Administrators & Sale of 18 Stores
14th Sep 20173:18 pmRNSUpdate regarding Just for Pets
7th Sep 20173:21 pmRNSExercise of Options
2nd Aug 201712:16 pmRNSESOP Trust Transaction
25th Jul 201711:22 amRNSWynnstay ESOP Trust Transactions
21st Jun 20177:00 amRNSHalf Year Results
5th Jun 20172:09 pmRNSHolding(s) in Company
25th May 201711:47 amRNSHolding(s) in Company
24th May 201711:48 amRNSHolding(s) in Company
24th May 20177:00 amRNSTrading Update
28th Apr 20177:00 amRNSScrip dividend elections
28th Mar 20179:00 amRNSAIM Disclosure Update
21st Mar 20175:02 pmRNSResult of AGM
21st Mar 20177:00 amRNSAGM Statement
10th Mar 201711:05 amRNSHolding(s) in Company
6th Feb 20177:00 amRNSBlock listing Interim Review
25th Jan 20177:00 amRNSFinal Results
24th Jan 20172:02 pmRNSAIM Disclosure Update
1st Nov 20169:34 amRNSScrip dividend election - Replacement
31st Oct 20165:00 pmRNSScrip dividend election
26th Oct 20162:37 pmRNSHolding(s) in Company
21st Sep 20164:28 pmRNSDirector/PDMR Shareholding
23rd Aug 20164:39 pmRNSDirector/PDMR Shareholding
26th Jul 20163:29 pmRNSEmployee SAYE Scheme & Director's Dealing
21st Jul 20169:17 amRNSDirector/PDMR Shareholding
7th Jul 201612:02 pmRNSDirector/PDMR Shareholding
29th Jun 20167:00 amRNSHalf-year Report
9th Jun 201610:18 amRNSHolding(s) in Company
29th Apr 20167:00 amRNSScrip dividend election
22nd Mar 20163:54 pmRNSResult of AGM
22nd Mar 20167:00 amRNSAGM Statement
18th Mar 20161:04 pmRNSWynnstay ESOP Trust Transactions
10th Mar 20167:00 amRNSDirector/PDMR Shareholding
5th Feb 20169:01 amRNSBlocklisting Interim Review
27th Jan 20167:35 amRNSBoard Appointment
27th Jan 20167:00 amRNSFinal Results
7th Dec 20151:39 pmRNSHolding(s) in Company
12th Nov 20159:42 amRNSScrip dividend election - Replacement
2nd Nov 20157:00 amRNSCompletion of Acquisition of Agricentre
30th Oct 20157:00 amRNSScrip dividend election
19th Oct 20157:00 amRNSAcquisition of Agricentre and Trading Update
5th Aug 20157:00 amRNSBlocklisting Interim Review
17th Jul 20153:07 pmRNSDirector/PDMR Shareholding
24th Jun 20157:00 amRNSHalf Yearly Report
1st May 20159:10 amRNSScript Dividend Elections

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.